Pathstone Holdings LLC grew its stake in ADT Inc. (NYSE:ADT – Free Report) by 3.6% during the third quarter, according to its ...

On Friday, ADT Inc (ADT) stock saw a modest uptick, ending the day at $7.54 which represents no change from the prior close of of $7.54. The stock opened at $7.57 and touched a low of $7.5 during the ...

Truqap combination showed a statistically and clinically meaningful improvement in radiographic progression-free survival for ...

The CAPItello-281 trial aimed to assess the safety and efficacy of Truqap in combination with abiraterone and ADT.

The JSE is confident that more companies will soon list on the bourse, but companies will have to time their entrance into ...

Data from a late-stage study shows that treatment with a three-drug combo involving AZN's Truqap benefits patients with an ...

The following is a summary of “High 11-ketotestosterone linked to shorter time to castration resistance in recurrent ...

Investigators explored the role of treatment intensification with androgen receptor pathway inhibitors in patients with high-risk localized prostate cancer.

AstraZeneca (AZN) reported positive results from a Phase 3 study of its drug Truqap in the treatment of a certain type of ...

ADT Medical Alert specializes in personal emergency response systems (PERS). Similar to ADT home security systems, these medical alert devices connect to a 24/7 monitoring center. The company ...

The height of the holiday shopping season is just a few days away as is the height of package theft season. Each day about 90 ...

British drug maker AstraZeneca Plc (AZN.L, AZN) announced Monday positive high-level results from CAPItello-281 Phase III trial of ...